IVF breakthrough: could a simple pill replace daily shots?
NCT ID NCT05954962
First seen Mar 29, 2026 · Last updated Apr 30, 2026 · Updated 5 times
Summary
This study tested whether an oral progesterone pill (Seidigestan®) works as well as standard daily injections (Astarté®) for preventing early ovulation in healthy egg donors undergoing IVF. 150 women aged 18-33 took part. The goal was to see if the pill could be a simpler, less painful option without reducing the number of mature eggs retrieved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IVF are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Instituto Bernabeu
Elche, Alicante, 03206, Spain
Conditions
Explore the condition pages connected to this study.